Bioavailable flavonoids: Cytochrome P450-mediated metabolism of methoxyflavones

Drug Metabolism and Disposition

Volumn 35, Issue 11, 2007, Pages 1985-1989

  Walle, U Kristina ^a   Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' METHOXYFLAVONE; 4' METHOXYFLAVONE; 5 METHOXYFLAVONE; 5,4' DIMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; 7,3' DIMETHOXYFLAVONE; CYTOCHROME P450; FLAVONE DERIVATIVE; FLAVONOID; METHOXYFLAVONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; FLAVONES; FLAVONOIDS; HUMANS; KAEMPFEROLS; LIVER; MICROSOMES, LIVER; MOLECULAR STRUCTURE; RECOMBINANT PROTEINS; SUBCELLULAR FRACTIONS;

EID: 35548940326     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.016782     Document Type: Article

References (32)

1. Ahmad F, Bakar SA, Ibrahim AZ, and Read RW (1997) Constituents of the leaves of Piper caninum. Planta Med 63:193-194.
2. Breinholt VM, Rasmussen SE, Brøsen K, and Friedberg TH (2003) In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s. Pharmacol Toxicol 93:14-22.
3. Drahushuk AT, McGarrigle BP, Larsen KE, Stegeman JJ, and Olson JR (1998) Detection of CYP1A1 protein in human liver and induction by TCDD in precision-cut liver slices incubated in dynamic organ culture. Carcinogenesis 19:1361-1368.
4. Harrigan JA, McGarrigle BP, Sutter TR, and Olson JR (2006) Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Toxicol In Vitro 20:426-438.
5. Jaipetch T, Reutrakul V, Tuntiwachwuttikul P, and Santisuk T (1983) Flavonoids in the black rhizomes of Boesenbergia pandurata. Phytochemistry 22:625-626.
6. Kurowska EM and Manthey JA (2004) Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. J Agric Food Chem 52:2879-2886.
7. Manach C and Donovan JL (2004) Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 38:771-785.
8. Middleton EJ, Kandaswami C, and Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673-751.
9. Morley KL, Ferguson PJ, and Koropatnick J (2007) Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 251:168-178.
10. Murakami A, Koshimizu K, Ohigashi H, Kuwahara S, Kuki W, Takahashi Y, Hosotani K, Kawahara S, and Matsuoka Y (2002) Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with luteolin. Biofactors 16:73-82.
11. Otake Y, Hsieh F, and Walle T (2002) Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos 30:576-581.
12. Otake Y and Walle T (2002) Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metab Dispos 30:103-105.
13. Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, and Zeldin DC (2006) The human intestinal cytochrome P450 "pie." Drug Metab Dispos 34:880-886.
14. Pan M-H, Chen W-J, Lin-Shiau S-Y, Ho C-T, and Line J-K (2002) Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23:1677-1684.
15. Rice-Evans C (2001) Flavonoid antioxidants. Curr Med Chem 8:797-807.
16. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
17. Stiborová M, Martínek V, Rydlová H, Koblas T, and Hodek P (2005) Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett 220:145-154.
18. Ta N and Walle T (2007) Aromatase inhibition by bioavailable methylated flavones. J Steroid Biochem Mol Biol 107:127-129.
19. Tsuji PA and Walle T (2006) Inhibition of benzo[a]pyrene- activating enzymes and DNA-binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis 27:1579-1585.
20. Tsuji PA, Winn RN, and Walle T (2006) Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. Chem Biol Interact 164:85-92.
21. Walle T (2007) Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin Cancer Biol 17:354-362.
22. Walle T, Otake Y, Brubaker JA, Walle UK, and Halushka PV (2001a) Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol 51:143-146.
23. Walle T, Ta N, Kawamori T, Wen X, Tsuji PA, and Walle UK (2007) Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem Pharmacol 73:1288-1296.
24. Walle T and Walle UK (2007) Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC-9 human oral cancer cells. J Pharm Pharmacol 59:857-862.
25. Walle T, Walle UK, and Halushka PV (2001b) Carbon dioxide is the major metabolite of quercetin in humans. J Nutr 131:2648-2652.
26. Wen X and Walle T (2006a) Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos 34:1786-1792.
27. Wen X and Walle T (2006b) Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 36:387-397.
28. Wen X and Walle T (2005) Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26:1774-1781.
29. Wen X, Walle UK, and Walle T (2005) 5,7-Dimethoxyflavone down-regulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26:803-809.
30. Williams RJ, Spencer JPE, and Rice-Evans C (2004) Flavonoids: antioxidants and signalling molecules? Free Radic Biol Med 36:838-849.
31. Williamson G and Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81:243S-255S.
32. Yenjai C, Prasanphen K, Daodee S, Wongpanich V, and Kittakoop P (2004) Bioactive flavonoids from Kaempferia parviflora. Fitoterapia 75:89-92.